{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T02:56:19Z","timestamp":1784343379252,"version":"3.55.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.psyneuen.2012.08.010","type":"journal-article","created":{"date-parts":[[2012,9,19]],"date-time":"2012-09-19T14:10:49Z","timestamp":1348063849000},"page":"767-776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression"],"prefix":"10.1016","volume":"38","author":[{"given":"Ladan","family":"Kashani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Targol","family":"Omidvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnoud","family":"Farazmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Modabbernia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Ramzanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ensiyeh Shahrokh","family":"Tehraninejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Ashrafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Tabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Akhondzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2012.08.010_bib0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2012.03.033","article-title":"Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study","author":"Abbasi","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0015","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1210\/en.2012-1134","article-title":"In vivo changes in central and peripheral insulin sensitivity in a large animal model of obesity","volume":"153","author":"Adam","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0020","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1007\/s00125-006-0500-4","article-title":"Associations between depressive symptoms and insulin resistance: the Hoorn study","volume":"49","author":"Adriaanse","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0025","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/da.20589","article-title":"Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial","volume":"26","author":"Akhondzadeh","year":"2009","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0030","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/JGP.0b013e3181b047e3","article-title":"Obesity and metabolic syndrome increase the risk of incident depression in older men: the health in men study","volume":"17","author":"Almeida","year":"2009","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0035","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1210\/jc.2008-1133","article-title":"Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial","volume":"94","author":"Aroda","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0040","article-title":"Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial","author":"Asadabadi","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0045","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1093\/humrep\/der197","article-title":"Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"26","author":"Barry","year":"2011","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-2094-4-3","article-title":"Effect of pioglitazone treatment on behavioral symptoms in autistic children","volume":"4","author":"Boris","year":"2007","journal-title":"J. Neuroinflam."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0055","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1177\/0269881111424456","article-title":"Involvement of PI3K GSK-3beta and PPARgamma in the antidepressant-like effect of folic acid in the forced swimming test in mice","volume":"26","author":"Budni","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0060","doi-asserted-by":"crossref","first-page":"E804","DOI":"10.1152\/ajpendo.00330.2002","article-title":"QUICKI is a useful index of insulin sensitivity in subjects with hypertension","volume":"284","author":"Chen","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0065","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1155\/2010\/573594","article-title":"Antidepressant effects on insulin sensitivity and proinflammatory cytokines in the depressed males","volume":"2010","author":"Chen","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0070","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/j.1471-4159.2006.03931.x","article-title":"Troglitazone, a peroxisome proliferator-activated receptor-gamma agonist, decreases tau phosphorylation in CHOtau4R cells","volume":"98","author":"d\u2019Abramo","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0075","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0015-0282(16)55249-2","article-title":"Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations","volume":"58","author":"Dale","year":"1992","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0080","first-page":"171","article-title":"Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseases","volume":"54","author":"De La Monte","year":"2012","journal-title":"Panmin. Med."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0085","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1185\/03007995.2012.681636","article-title":"A systematic review and meta-analysis of randomized controlled trials comparing pioglitazone versus metformin in the treatment of polycystic ovary syndrome","volume":"28","author":"Du","year":"2012","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0090","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/FBP.0b013e328331b9bf","article-title":"Antidepressant-like effects of rosiglitazone, a PPARgamma agonist, in the rat forced swim and mouse tail suspension tests","volume":"20","author":"Eissa Ahmed","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0095","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.2337\/diacare.27.12.2856","article-title":"Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife","volume":"27","author":"Everson-Rose","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0100","doi-asserted-by":"crossref","first-page":"37006","DOI":"10.1074\/jbc.M700447200","article-title":"Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis","volume":"282","author":"Fuenzalida","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0105","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1017\/S1461145710000970","article-title":"Is there a role for the nuclear receptor PPARgamma in neuropsychiatric diseases?","volume":"13","author":"Garcia-Bueno","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0110","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuropharm.2011.01.033","article-title":"Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes","volume":"60","author":"Gupta","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0120","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbalip.2007.04.016","article-title":"PPARs in the brain","volume":"1771","author":"Heneka","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0125","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.psyneuen.2011.04.001","article-title":"Sex steroids, insulin sensitivity and sympathetic nerve activity in relation to affective symptoms in women with polycystic ovary syndrome","volume":"36","author":"Jedel","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0130","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/humrep\/dep384","article-title":"Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index","volume":"25","author":"Jedel","year":"2010","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0135","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00011-010-0203-7","article-title":"PPARgamma agonist pioglitazone inhibits microglia inflammation by blocking p38 mitogen-activated protein kinase signaling pathways","volume":"59","author":"Ji","year":"2010","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fnmol.2011.00016","article-title":"Glycogen synthase kinase-3 in the etiology and treatment of mood disorders","volume":"4","author":"Jope","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0145","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jneuroim.2009.04.011","article-title":"A pilot test of pioglitazone as an add-on in patients with relapsing remitting multiple sclerosis","volume":"211","author":"Kaiser","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pbb.2010.04.018","article-title":"Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor-Upsilon (PPARUpsilon) in Huntington's disease","volume":"96","author":"Kalonia","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0155","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jad.2011.09.024","article-title":"Protein levels of beta-catenin and activation state of glycogen synthase kinase-3beta in major depression. A study with postmortem prefrontal cortex","volume":"136","author":"Karege","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0160","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1176\/appi.ajp.2008.08081195","article-title":"Antidepressant response associated with pioglitazone: support for an overlapping pathophysiology between major depression and metabolic syndrome","volume":"166","author":"Kemp","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0165","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.jad.2011.06.033","article-title":"Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity","volume":"136","author":"Kemp","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0170","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5653\/cerm.2011.38.2.98","article-title":"Pioglitazone treatment decreases follicular fluid levels of tumor necrosis factor-alpha and interleukin-6 in patients with polycystic ovary syndrome","volume":"38","author":"Kim","year":"2011","journal-title":"Clin. Exp. Reprod. Med."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0175","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.fertnstert.2009.02.029","article-title":"Effects of pioglitazone on ovarian stromal blood flow, ovarian stimulation, and in vitro fertilization outcome in patients with polycystic ovary syndrome","volume":"94","author":"Kim","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(02)02480-0","article-title":"Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2","volume":"941","author":"Kim","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0185","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4088\/JCP.v69n0202","article-title":"Metabolic syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study","volume":"69","author":"Koponen","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2006.12.025","article-title":"The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome","volume":"196","author":"Legro","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0195","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2337\/dc10-1068","article-title":"Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study","volume":"34","author":"Lewis","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0200","article-title":"Pioglitazone and bladder cancer: a propensity score matched cohort study","author":"Li","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0205","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ypmed.2012.03.004","article-title":"Associations between anxious-depressed symptoms and cardiovascular risk factors in a longitudinal childhood study","volume":"54","author":"Louise","year":"2012","journal-title":"Prev. Med."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0210","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1345\/aph.1Q238","article-title":"Rosiglitazone and pioglitazone for the treatment of Alzheimer's disease","volume":"45","author":"Miller","year":"2011","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0215","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/193229681000400219","article-title":"Glucose supply and insulin demand dynamics of antidiabetic agents","volume":"4","author":"Monte","year":"2010","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0220","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/sj.mp.4001805","article-title":"The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine","volume":"11","author":"Muller","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0225","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1590\/S0100-879X2008001200001","article-title":"Stress-induced neuroinflammation: mechanisms and new pharmacological targets","volume":"41","author":"Munhoz","year":"2008","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0230","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.neuron.2011.07.018","article-title":"Tracking down the molecular substrates of stress: new roles for p38alpha MAPK and kappa-opioid receptors","volume":"71","author":"Muschamp","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0235","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s00125-012-2538-9","article-title":"Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study","volume":"55","author":"Neumann","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0240","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1053\/meta.2000.9515","article-title":"Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis","volume":"49","author":"Okamura","year":"2000","journal-title":"Metabolism."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0245","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.tips.2011.06.006","article-title":"The role of metformin and thiazolidinediones in the regulation of hepatic glucose metabolism and its clinical impact","volume":"32","author":"Phielix","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0250","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1210\/en.2011-1502","article-title":"PPARgamma agonist improves neuronal insulin receptor function in hippocampus and brain mitochondria function in rats with insulin resistance induced by long term high-fat diets","volume":"153","author":"Pipatpiboon","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0255","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.brainres.2011.09.056","article-title":"Lithium, phenserine, memantine and pioglitazone reverse memory deficit and restore phospho-GSK3beta decreased in hippocampus in intracerebroventricular streptozotocin induced memory deficit model","volume":"1426","author":"Ponce-Lopez","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0260","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1590\/S0100-72032012000200006","article-title":"Insulin resistance in women with polycystic ovary syndrome: relationship with anthropometric and biochemical variables","volume":"34","author":"Pontes","year":"2012","journal-title":"Rev. Bras. Ginecol. Obstet."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0265","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/1568005310202010097","article-title":"Common treatment of polycystic ovarian syndrome and major depressive disorder: case report and review","volume":"2","author":"Rasgon","year":"2002","journal-title":"Curr. Drug Targets Immune Endocr. Metabol. Disord."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0270","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1100\/tsw.2010.32","article-title":"Rosiglitazone add-on in treatment of depressed patients with insulin resistance: a pilot study","volume":"10","author":"Rasgon","year":"2010","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0275","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.pnpbp.2008.05.020","article-title":"Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice","volume":"32","author":"Rosa","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0280","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/PSY.0b013e31824d0865","article-title":"A neural circuitry linking insulin resistance to depressed mood","volume":"74","author":"Ryan","year":"2012","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0285","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbr.2011.06.011","article-title":"Antidepressant-like effect of pioglitazone in the forced swimming test in mice: the role of PPAR-gamma receptor and nitric oxide pathway","volume":"224","author":"Sadaghiani","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0290","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-012-2722-0","article-title":"NMDA receptor involvement in antidepressant-like effect of pioglitazone in the forced swimming test in mice","author":"Salehi-Sadaghiani","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0295","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/npp.2012.58","article-title":"Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial","volume":"37","author":"Sepanjnia","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0300","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1399-5448.2009.00606.x","article-title":"Psychological symptoms and insulin sensitivity in adolescents","volume":"11","author":"Shomaker","year":"2010","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0305","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2002-030024","article-title":"Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders","volume":"89","author":"Skrha","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0310","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2337\/diabetes.47.4.507","article-title":"PPAR-gamma: adipogenic regulator and thiazolidinedione receptor","volume":"47","author":"Spiegelman","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0315","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/bmj.38313.513310.F71","article-title":"Insulin resistance and depression: cross-sectional study","volume":"330","author":"Timonen","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0320","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/PSY.0b013e318157ad2e","article-title":"Insulin resistance and depressive symptoms in young adult males: findings from Finnish military conscripts","volume":"69","author":"Timonen","year":"2007","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0325","doi-asserted-by":"crossref","first-page":"677","DOI":"10.4088\/JCP.10m06743","article-title":"Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison","volume":"72","author":"Trivedi","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0330","first-page":"571035","article-title":"The usefulness of homeostatic measurement assessment-insulin resistance (HOMA-IR) for detection of glucose intolerance in Thai women of reproductive age with polycystic ovary syndrome","volume":"2012","author":"Wongwananuruk","year":"2012","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0335","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/09513590500231627","article-title":"The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome","volume":"21","author":"Yilmaz","year":"2005","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.psyneuen.2012.08.010_bib0340","first-page":"387","article-title":"Leptin, adiponectin, leptin to adiponectin ratio and insulin resistance in depressive women","volume":"30","author":"Zeman","year":"2009","journal-title":"Neuro Endocrinol. Lett."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453012003010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453012003010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:41:32Z","timestamp":1759682492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453012003010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0306453012003010"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2012.08.010","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2012.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}